Epstein–Barr virus associated peri-implantitis: a split-mouth study

作者: Fernando Verdugo , Ana Castillo , Francisca Castillo , Agurne Uribarri

DOI: 10.1007/S00784-014-1250-1

关键词:

摘要: Herpesviral–bacterial synergism may play a potential role in periodontitis and peri-implantitis (PI) etiopathogenesis. PI lesions can worsen depending on specific microbial challenge host susceptibility. This cross-sectional split-mouth study aimed to substantiate herpesviral–bacterial co-infection patients assess associations with periodontopathogen salivary contamination. PCR-based identification was performed 23 presenting contralateral healthy implants, compared unstimulated whole saliva. Clinical evaluation included probing depths, bleeding probing, suppuration. Radiographs were assessed for the presence of lamina dura bone loss. Three sample sites per patient tested: lesions, implant sulci, Quantitative PCR evaluated Epstein–Barr virus (EBV) cytomegalovirus (CMV) copy counts. Significance group comparisons binary-dependent variables, within-subjects designs, determined by McNemar's chi-square test. Risk analysis through odds ratios (OR). 14.2 (P = 0.001; 95 % confidence interval [CI], 1.6–124.1) 3 times (P = 0.03; CI, 0.7–11.9) more likely harbor EBV than implants saliva, respectively. positive predictive value 90 %. associated absence higher proportions. Saliva sampling showed high agreement bacterial detection (89–100 % rate) but not (44.4 %). The OR harboring Treponema denticola or Tannerella forsythia 6.79 (P = 0.007; 1.8–25.0) 3.3 (P < 0.0001; 0.3–34.3) 5.6 be contaminated Prevotella nigrescens peri-implant sulci (P = 0.002). 1.92 (P = 0.04). is candidate useful predicting peri-implantitis-specific infection CMV. favor ongoing disease exacerbate its progression. explain non-responsive treatment PI. Peri-implantitis individuals benefit from antiviral therapy.

参考文章(38)
Maria Gabriella Grusovin, Helen V Worthington, Marco Esposito, Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review. European Journal of Oral Implantology. ,vol. 5, ,(2012)
Christian Sinzger, Barbara Adler, Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread? Thrombosis and Haemostasis. ,vol. 102, pp. 1057- 1063 ,(2009) , 10.1160/TH09-04-0213
I. Saygun, N. Nizam, I. Keskiner, V. Bal, A. Kubar, C. Açıkel, M. Serdar, J. Slots, Salivary infectious agents and periodontal disease status. Journal of Periodontal Research. ,vol. 46, pp. 235- 239 ,(2011) , 10.1111/J.1600-0765.2010.01335.X
S Jankovic, Z Aleksic, B Dimitrijevic, V Lekovic, I Milinkovic, B Kenney, Correlation between different genotypes of human cytomegalovirus and Epstein-Barr virus and peri-implant tissue status. Australian Dental Journal. ,vol. 56, pp. 382- 388 ,(2011) , 10.1111/J.1834-7819.2011.01360.X
Fernando Verdugo, Ana Castillo, Krikor Simonian, Francisca Castillo, Esther Farez-Vidal, Antonio D'Addona, Periodontopathogen and Epstein–Barr Virus‐Associated Periapical Periodontitis May Be the Source of Retrograde Infectious Peri‐Implantitis Clinical Implant Dentistry and Related Research. ,vol. 17, pp. 199- 207 ,(2015) , 10.1111/CID.12083
Martin Savard, Jean Gosselin, Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus Research. ,vol. 119, pp. 134- 145 ,(2006) , 10.1016/J.VIRUSRES.2006.02.008
Séverine Vincent-Bugnas, Sébastien Vitale, Caroline C. Mouline, Wafa Khaali, Yves Charbit, Patrick Mahler, Isabelle Prêcheur, Paul Hofman, Janet L. Maryanski, Alain Doglio, EBV Infection Is Common in Gingival Epithelial Cells of the Periodontium and Worsens during Chronic Periodontitis PLoS ONE. ,vol. 8, pp. e80336- ,(2013) , 10.1371/JOURNAL.PONE.0080336
Jan Lindhe, Joerg Meyle, , Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology Journal of Clinical Periodontology. ,vol. 35, pp. 282- 285 ,(2008) , 10.1111/J.1600-051X.2008.01283.X
Pia Titterud Sunde, Ingar Olsen, Morten Enersen, Bjørn Grinde, Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy. Journal of Clinical Virology. ,vol. 42, pp. 176- 178 ,(2008) , 10.1016/J.JCV.2008.01.007